---
categories: 
- Database
- Release
date: 2024-07-11
title: Database release
---
Added entries:
- (FDA) _KRAS_ p.G12C and sensitivity to adagrasib in combination with cetuximab for patients with colorectal cancer received accelerated approval. 
- (FDA) _NTRK1/2/3_ gene fusions and sensitivity to repotrectinib for patients with solid tumors received accelerated approval.

Revised entries:
- (FDA) _RET_ fusions and sensitivity to selpercatinib for patients with thyroid cancer received traditional approval from the FDA, from accelerated approval.